Changes of metabolic profiles in urine after oral administration of quercetin in rats

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1521-1527

  An, Daizhi ^a   Zhang, Qi ^b   Wu, Shengmin ^b   Wei, Jingyu ^a   Yang, Jijun ^a   Dong, Fangting ^b   Yan, Xianzhong ^b   Guo, Changjiang ^a  

^a INSTITUTE OF HEALTH AND ENVIRONMENTAL MEDICINE   (China)

^b NATIONAL CENTER OF BIOMEDICAL ANALYSIS   (China)

Author keywords

HPLC MS; Metabolomics; NMR; Quercetin; Urine

Indexed keywords

2 OXOGLUTARIC ACID; ACETIC ACID; ALANINE; CHOLINE; CITRIC ACID; CREATININE; DIMETHYLGLYCINE; DRUG METABOLITE; HIPPURIC ACID; LACTIC ACID; QUERCETIN; SUCCINIC ACID; TAURINE; TRIMETHYLAMINE OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; IN VIVO STUDY; MALE; METABOLOMICS; NONHUMAN; RAT; SINGLE DRUG DOSE; URINALYSIS;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; METABOLOMICS; QUERCETIN; RATS; RATS, WISTAR; URINALYSIS;

RATTUS;

EID: 77952880084     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.019     Document Type: Article

References (46)

1. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radical Biol. Med. 2000, 28:1056-1067.
2. Bieger J., Cermak R., Blank R., de Boer V.C.J., Hollman P.C.H., Kamphues J., Wolffram S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr. 2008, 138:1417-1420.
3. Boots A.W., Haenen G.R.M.M., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
4. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationship. Free Radical Biol. Med. 1997, 22:749-760.
5. Ciolino H.P., Daschner P.J., Yeh G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999, 340(Pt 3):715-722.
6. Clifford M.N., Copeland E.L., Bloxsidge J.P., Mitchell L.A. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica 2000, 30:317-326.
7. 1H NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery. Biomarker 2004, 9:156-179.
8. Constantinou A., Mehta R., Runyan C., Rao K., Vaughan A., Moon R. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J. Nat. Prod. 1995, 58:217-225.
9. Cotelle N. Role of flavonoids in oxidative stress. Curr. Top. Med. Chem. 2001, 1:569-590.
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
11. Day A.J., Mellon F., Barron D., Sarrazin G., Morgan M.R.A., Williamson G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res. 2001, 35:941-952.
12. Daykin C.A., Van Duynhoven J.P.M., Groenewegen A., Dachtler M., Van Amelsvoort J.M.M., Mulder T.P.J. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J. Agric. Food. Chem. 2005, 53:1428-1434.
13. De Boer V.C.J., Dihal A.A., van der Woude H., Arts I.C.W., Wolffram S., Alink G.M., Rietjens I.M.C.M., Keijer J., Hollman P.C.H. Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005, 135:1617-1618.
14. Dorta D.J., Pigoso A.A., Mingaytto F.E., Rodrigues T., Prado I.M.R., Helena A.F.C., Uyemura S.A., Santos A.C., Curti C. The interaction of flavonoids with mitochondria: effects on energetic processes. Chem. Biol. Interact. 2005, 152:67-78.
15. Duarte J., Perez-Palencia R., Vargas F., Ocete M.A., Perez-Vozcaino F., Zarzuelo A., Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 2001, 133:117-124.
16. Dunn W.B., Ellis D.I. Metabolomics: current analytical platforms and methodologies. Trends Anal. Chem. 2005, 24:285-294.
17. 13C NMR. NMR Biomed. 2005, 18:331-336.
18. Holmes E., Nicholls A.W., Lindon J.C., Connor S.C., Connelly J.C., Haselden J.N., Damment S.J.P., Spraul M., Neidig P., Nicholson J.K. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem. Res. Toxicol. 2000, 13:471-478.
19. Jovanovic S.V., Steenken S., Tosic M., Marjanovic B., Simic M.G. Flavonoids as antioxidants. J. Am. Chem. Soc. 1994, 116:4846-4851.
20. Justino G.C., Santos M.R., Canario S., Borges C., Florencio M.H., Mira L. Plasma quercetin metabolites: structure-antioxidant activity relationships. Arch. Biochem. Biophys. 2004, 432:109-121.
21. Kahraman A., Erhasap N., Serteser M., Koken T. Protective effect of quercetin on renal ischemia/reperfusion injury in rats. J. Nephrol. 2003, 16:219-224.
22. Leighton F., Bergseth S., Rørtveit T., Christiansen E.C., Bremer J. Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. J. Biol. Chem. 1989, 264:10347-10350.
23. 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J. Pharm. Biomed. Anal. 2003, 33:1103-1115.
24. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
25. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2003, 301:1069-1078.
26. Moskaug J.Ø., Carlsen H., Myhrstad M., Blomhoff R. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev. 2004, 125:315-324.
27. Nagao A., Seki M., Kobayashi H. Inhibition of xanthine oxidase by flavonoids. Biosci. Biotechnol. Biochem. 1999, 63:1787-1790.
28. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
29. Rao M.K., Ghosh B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages. Int. J. Immunopharmacol. 1999, 21:435-443.
30. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
31. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationship of flavonoids and phenolic acids. Free Radical Biol. Med. 1996, 20:933-956.
32. Rohrdanz E., Bittner A., Tran-Thi Q.H., Kahl R. The effect of quercetin on the mRNA expression of different antioxidant enzymes in hepatoma cells. Arch. Toxicol. 2003, 77:506-510.
33. Sestili P., Guidareli A., Dacha M., Cantoni M. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide free radical scavenging versus iron chelating mechanism. Free Radical Biol. Med. 1998, 25:196-200.
34. Solanky K.S., Bailey N.J.C., Holmes E., Lindon J.C., Davis A.L., Mulder T.P.J., Van Duynhoven J.P.M., Nicholson J.K. NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat. J. Agric. Food Chem. 2003, 51:4139-4145.
35. 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of biochemical effects of dietary isoflavones on human plasma profile. Anal. Biochem. 2003, 323:197-204.
36. 1H NMR-based metabonomic techniques in nutrition research-metabolic effects of dietary isoflavones in humans. J. Nutr. Biochem. 2005, 16:236-244.
37. Spencer J.P.E., Kuhnle G.G.C., Williams R.J., Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J. 2003, 372:173-181.
38. Su J.F., Guo C.J., Wei J.Y., Yang J.J., Jiang Y.G., Li Y.F. Study on the absorption of quercetin and rutin at different segments of intestine. J. Hyg. Res. 2002, 31:55-57.
39. Su J.F., Guo C.J., Wei J.Y., Yang J.J. Antioxidant capacity of quercetin in vitro and in vivo. Chin. J. Appl. Physiol. 2002, 18:382-386.
40. Su J.F., Guo C.J., Wei J.Y., Yang J.J., Jiang Y.G., Li Y.F. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed. Environ. Sci. 2003, 16:1-8.
41. Trumbeckaite S., Bernatoniene J., Majiene D., Jakštas V., Savickas A., Toleikis A. The effect of flavonoids on rat heart mitochondrial function. Biomed. Pharmacother. 2006, 60:245-248.
42. Van Dorsten F.A., Daykin C.A., Mulder T.P.J., Van Duynhoven J.P.M. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J. Agric. Food Chem. 2006, 54:6929-6938.
43. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell. 2000, 6:909-919.
44. Wang L., Morris M.E. Liquid chromatography-tandem mass spectroscopy assay for quercetin and conjugated quercetin metabolites in human plasma and urine. J. Chromatogr. B 2005, 821:194-201.
45. Wittig J., Herderich M., Graefe E.U., Veit M. Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2001, 753:237-243.
46. Yamamoto N., Moon J.H., Tsushida T., Nagao A., Terao J. Inhibitory effects of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch. Biochem. Biophys. 1999, 372:347-354.